Chronic back pain and spine-related conditions bring some of the most hopeful patient inquiries to this field — and also some of the most important honesty about what current evidence actually supports.
As of 2026, neither the FDA nor INVIMA (Colombia's regulatory authority) has approved stem cell, PRP, or exosome products specifically for most orthopedic or aesthetic indications. This does not mean these treatments are unsafe or ineffective — it means they operate in a space where clinical evidence and regulatory approval haven't yet aligned. Any provider should be transparent about this distinction.
What's being researched
Stem cell approaches for disc degeneration and related chronic back pain are an active area of investigation, generally with an evolving rather than fully established evidence base — earlier-stage than the knee osteoarthritis research covered in our dedicated guide.
Spine anatomy is complex, and back pain has many possible underlying causes — not all of which are appropriate candidates for regenerative treatment. A thorough diagnostic workup identifying your specific pain generator is essential before considering this option, not an optional first step.
What a responsible evaluation should include
- Imaging (MRI) to identify the specific structural cause of your pain
- A clear explanation of whether your specific diagnosis falls within the evidence-supported scope for this treatment
- Discussion of more established alternatives — physical therapy, injections, or surgical options — and where regenerative treatment fits relative to those
Why this deserves extra scrutiny
Chronic back pain is an area where patients are often highly motivated to try anything that might help — exactly the situation where overstated claims are most tempting to believe and most important to evaluate critically. A responsible provider will be direct about the honest evidence limitations here.
The realistic bottom line
This remains a genuinely developing area of the field — worth discussing with a physician as one option among several, with clear eyes about the current evidence base, rather than approaching it as an established solution.
Ready to talk to someone?
Message us on WhatsApp for a free, no-obligation consultation.